Literature Citations
1. New Fluoroquinolones/Nitric oxide Donor Hybrids: Design, Synthesis and Antitubercular Activity. Aziz, H.A., G.A.I. Moustafa, S.H. Abbas, G. Hauk, V.S. Krishna, D. Sriram, J.M. Berger, and G.E.A. Abuo-Rahma. Medicinal Chemistry Research, 2019. 28(8): p. 1272-1283. ISI[000472968400014].
[WOS]. TB_07_2019.
2. Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production. Choi, S.R., B.E. Britigan, and P. Narayanasamy. mSphere, 2019. 4(4): e00443-00419. PMID[31341073]. PMCID[PMC6656872].
[PubMed]. TB_07_2019.
3. Evaluation of in Silico Designed Inhibitors Targeting MelF (Rv1936) against Mycobacterium marinum within Macrophages. Dharra, R., V.S. Radhakrishnan, T. Prasad, Z. Thakur, J.D. Cirillo, A. Sheoran, A.K. Pandey, M. Kulharia, and P.K. Mehta. Scientific Reports, 2019. 9(10084): 11pp. PMID[31300732]. PMCID[PMC6626058].
[PubMed]. TB_07_2019.
4. Synthesis and Biological Evaluation of New Eugenol-derived 1,2,3-Triazoles as Antimycobacterial Agents. dos Santos, T., C.M. Coelho, T.C. Elias, F.S. Siqueira, E. Nora, M.M.A. de Campos, G.A.P. de Souza, L.F.L. Coelho, and D.T. Carvalhoe. Journal of the Brazilian Chemical Society, 2019. 30(7): p. 1425-1436. ISI[000472842700008].
[WOS]. TB_07_2019.
5. The Chemical Composition of the Essential Oil, SPME and Antimicrobial Activity of Rhododendron caucasicum Pall. Fandakli, S., N. Yayli, N. Kahriman, E. Uzunalioglu, N.U. Colak, S. Yildirim, and A. Yasar. Records of Natural Products, 2019. 13(4): p. 316-323. ISI[000472482800005].
[WOS]. TB_07_2019.
6. Synthesis and Antimicrobial Activity of Novel Thiazoles with Reactive Functional Groups. Grybaite, B., R. Vaickelioniene, M. Stasevych, O. Komaroyska-Porokhnyayets, K. Kantminiene, V. Novikov, and V. Mickevicius. ChemistrySelect, 2019. 4(23): p. 6965-6970. ISI[000472522700019].
[WOS]. TB_07_2019.
7. Dithiodiketopiperazine Derivatives from Endophytic Fungi Trichoderma harzianum and Epicoccum nigrum. Harwoko, H., G. Daletos, F. Stuhldreier, J. Lee, S. Wesselborg, M. Feldbrugge, W.E.G. Muller, R. Kalscheuer, E. Ancheeva, and P. Proksch. Natural Product Research, 2019: p. 1-9. PMID[31210064].
[PubMed]. TB_07_2019.
8. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation Towards Mycobacterium tuberculosis and Plasmodium falciparum. Kiefer, A., C.D. Bader, J. Held, A. Esser, J. Rybniker, M. Empting, R. Muller, and U. Kazmaier. Chemistry, 2019. 25(37): p. 8894-8902. PMID[31012978].
[PubMed]. TB_07_2019.
9. In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-resistant Clinical Isolates. Kim, D.H., B.W. Jhun, S.M. Moon, S.Y. Kim, K. Jeon, O.J. Kwon, H.J. Huh, N.Y. Lee, S.J. Shin, C.L. Daley, and W.J. Koh. Antimicrobial Agents and Chemotherapy, 2019. 63(8): e00665-00619. PMID[31182533].
[PubMed]. TB_07_2019.
10. In Vitro Inhibition of Twenty Three Anti-tuberculosis Drugs on Six UGT Enzymes. Kim, M.J., J.G. Ha, S.E. Yoo, H.S. Kim, D.H. Kim, and J.G. Shin. European Journal of Clinical Pharmacology, 2019. 75: p. S44-S44. ISI[000473043400096].
[WOS]. TB_07_2019.
11. Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-infected Macrophages. Lu, L., J. Arranz-Trullen, G. Prats-Ejarque, D. Pulido, S. Bhakta, and E. Boix. Frontiers in Immunology, 2019. 10: p. 1500. PMID[31312205]. PMCID[PMC6614385].
[PubMed]. TB_07_2019.
12. Efficacy of Carvacrol against Resistant Rapidly Growing Mycobacteria in the Planktonic and Biofilm Growth Mode. Marini, E., M. Di Giulio, G. Ginestra, G. Magi, S. Di Lodovico, A. Marino, B. Facinelli, L. Cellini, and A. Nostro. Plos One, 2019. 14(7): e0219038. PMID[31260476]. PMCID[PMC6602199].
[PubMed]. TB_07_2019.
13. Novel 5-Substituted Derivatives of 2'-Deoxy-6-azauridine with Antibacterial Activity. Negrya, S.D., O.V. Efremenkova, P.N. Solyev, V.O. Chekhov, M.A. Ivanov, I.G. Sumarukova, I.L. Karpenko, S.N. Kochetkov, and L.A. Alexandrova. Journal of Antibiotics, 2019. 72(7): p. 535-544. PMID[30792519].
[PubMed]. TB_07_2019.
14. Design, Synthesis and Anti-tuberculosis Activity of Hydrazones and N-Acylhydrazones Containing Vitamin B-6 and Different Heteroaromatic Nucleus. Nogueira, T.C.M., L.D. Cruz, M.C. Lourenco, and M.V.N. de Souza. Letters in Drug Design & Discovery, 2019. 16(7): p. 792-798. ISI[000473100200008].
[WOS]. TB_07_2019.
15. IP-10 Contributes to the Inhibition of Mycobacterial Growth in an ex Vivo Whole Blood Assay. Palucci, I., B. Battah, A. Salustri, F. De Maio, L. Petrone, F. Ciccosanti, M. Sali, V. Bondet, D. Duffy, G.M. Fimia, D. Goletti, and G. Delogu. International Journal of Medical Microbiology, 2019. 309(5): p. 299-306. PMID[31147175].
[PubMed]. TB_07_2019.
16. Clostrindolin Is an Antimycobacterial Pyrone Alkaloid from Clostridium beijerinckii. Schieferdecker, S., G. Shabuer, U. Knuepfer, and C. Hertweck. Organic and Biomolecular Chemistry, 2019. 17(25): p. 6119-6121. PMID[31168541].
[PubMed]. TB_07_2019.
17. Design, Synthesis, Anti-mycobacterial and Cytotoxic Evaluation of C-4 Functionalized 1,8-Naphthalimide-heterocyclic Hydrazide Conjugates. Shalini, M.D. Johansen, L. Kremer, and V. Kumar. Chemical Biology and Drug Design, 2019. 94(1): p. 1300-1305. PMID[30776195].
[PubMed]. TB_07_2019.
18. Synergistic Efficacy of Beta-lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice. Story-Roller, E., E.C. Maggioncalda, and G. Lamichhane. Antimicrobial Agents and Chemotherapy, 2019. 63(8): e00614-00619. PMID[31109979].
[PubMed]. TB_07_2019.
19. Tetraethylene glycol Tethered Homonuclear and Heteronuclear Isatin Dimers and Their in Vitro Anti-mycobacterial Activities. Wang, Y.L., S.J. Zhao, J.L. Deng, Z.S. Lv, and Z. Xu. Revue Roumaine de Chimie, 2019. 64(2): p. 199-204. ISI[000472725200010].
[WOS]. TB_07_2019.
20. Dual-targeting GroEL/ES Chaperonin and Protein Tyrosine Phosphatase B (PtpB) Inhibitors: A Polypharmacology Strategy for Treating Mycobacterium tuberculosis Infections. Washburn, A., S. Abdeen, Y. Ovechkina, A.M. Ray, M. Stevens, S. Chitre, J. Sivinski, Y. Park, J. Johnson, Q.Q. Hoang, E. Chapman, T. Parish, and S.M. Johnson. Bioorganic and Medicinal Chemistry Letters, 2019. 29(13): p. 1665-1672. PMID[31047750]. PMCID[PMC6531345].
[PubMed]. TB_07_2019.
21. Comparison of in Vitro Activity of the Nitroimidazoles Delamanid and Pretomanid against Multidrug-resistant and Extensively Drug-resistant Tuberculosis. Wen, S., W. Jing, T. Zhang, Z. Zong, Y. Xue, Y. Shang, F. Wang, H. Huang, N. Chu, and Y. Pang. European Journal of Clinical Microbiology and Infectious Diseases, 2019. 38(7): p. 1293-1296. PMID[30953211].
[PubMed]. TB_07_2019.
22. In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China. Yu, X., X. Gao, C. Li, J. Luo, S. Wen, T. Zhang, Y. Ma, L. Dong, F. Wang, and H. Huang. Antimicrobial Agents and Chemotherapy, 2019. 63(8): e00031-00019. PMID[31138571].
[PubMed]. TB_07_2019.
Patent Citations
23. Tiacumicin Derivatives and Their Use as Antibiotics for Use in Treatment of Bacterial Infections Caused by Drug Resistant Bacteria.Gademann, K., R. Berg, and A. Meier. Patent. 2019. 2019-EP50353 2019135010: 65pp.
[Patent]. TB_07_2019.
24. Phenanthrolinone Derivatives for Use in the Treatment of Bacterial Infections. Gicquel, B., M. Cimino, P. Dallemagne, C. Rochais, S. Coulibaly, and M. Ouattara. Patent. 2019. 2019-EP50713 2019138084: 46pp.
[Patent]. TB_07_2019.
25. Preparation of Secondary Amine Compounds as tRNA Synthetase Inhibitors Useful in Killing Gram-negative Bacteria. Kahne, D.E. and V. Baidin. Patent. 2019. 2019-US13305 2019140265: 331pp.
[Patent]. TB_07_2019.
26. Multicyclic Compounds and Use of Same for Treating Tuberculosis. Kahne, D.E., V. Baidin, E.J. Rubin, and R.E. Audette. Patent. 2019. 2019-US13290 2019140254: 125pp.
[Patent]. TB_07_2019.